Clavel; Francois

Patent Applications and Registrations

Patent applications and USPTO patent grants for Clavel; Francois.The latest application filed is for "nucleotide sequences of hiv-1 group (or subgroup) o retroviral antigens".

Company Profile

0.16.14

Clavel; Francois - Paris FR
Clavel; Francois - Rockville MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Nucleotide sequences of HIV-1 group (or subgroup) O retroviral antigens Grant 8,236,324 - Charneau , et al. August 7, 2	2012-08-07
Nucleotide sequences of HIV-1 group (or subgroup) O retroviral antigens App 20080261197 - Charneau; Pierre ; et al.	2008-10-23
HIV-2 antigen compositions Grant 7,341,731 - Montagnier , et al. March 11, 2	2008-03-11
Method for analysis of the phenotypic characteristics of the human immunodeficiency virus (HIV) App 20070269797 - Clavel; Francois ; et al.	2007-11-22
Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens Grant 7,157,225 - Charneau , et al. January 2, 2	2007-01-02
Retrovirus capable of causing AIDS, means and methods for detecting it in vitro Grant 7,115,363 - Montagnier , et al. October 3, 2	2006-10-03
Human immunodeficiency virus type 2 (HIV-2) env polypeptide and diagnostic assays Grant 6,979,535 - Alizon , et al. December 27, 2	2005-12-27
Method for analysis of the phenoptypic characteristics of the human immunodeficiency virus (HIV) App 20040101828 - Clavel, Francois ; et al.	2004-05-27
Method for analysing human immunodeficiency virus (HIV) phenotypic characteristics App 20040053219 - Clavel, Francois ; et al.	2004-03-18
Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits App 20030235835 - Alizon, Marc ; et al.	2003-12-25
Method for analysing immunodeficiency virus (HIV) phenotypic characteristics App 20030207294 - Clavel, Francois ; et al.	2003-11-06
Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits App 20030186219 - Alizon, Marc ; et al.	2003-10-02
HIV-2 antigen compositions App 20030170658 - Montagnier, Luc ; et al.	2003-09-11
Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits App 20030091985 - Alizon, Marc ; et al.	2003-05-15
Human immunodeficiency virus type 2 (HIV-2) env polypeptide and diagnostic assays App 20030082523 - Alizon, Marc ; et al.	2003-05-01
Methods and kits for diagnosing human immunodeficiency virus type 2 (HIV-2), proteins of HIV-2, and vaccinating agents for HIV-2 Grant 6,544,728 - Alizon , et al. April 8, 2	2003-04-08
Nucleotide sequences of HIV-1 group (or subgroup) O retroviral antigens App 20030049604 - Charneau, Pierre ; et al.	2003-03-13
Method for analysing human immunodeficiency virus (HIV) phenotypic characteristics App 20020123036 - Clavel, Francois ; et al.	2002-09-05
Rapid single-cycle assay for human immunodeficiency virus type 1 drug resistance App 20020119444 - Paulous, Sylvie ; et al.	2002-08-29
A Method For Preparing A Viral Extract Containing Hiv-ii Rna App 20020051967 - Montagnier, Luc ; et al.	2002-05-02
Nucleic acid-based methods for the detection of human immunodeficiency virus type 2 (HIV-2) Grant 6,316,183 - Alizon , et al. November 13, 2	2001-11-13
Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and the use of these DNA clones polypeptides in diagnostic kits Grant 6,261,762 - Alizon , et al. July 17, 2	2001-07-17
Human immunodeficiency virus type 2 (HIV-2) polypeptides and methods of producing them Grant 6,162,439 - Alizon , et al. December 19, 2	2000-12-19
Rapid single-cycle assay for human immunodeficiency virus type-1 drug resistance Grant 6,103,462 - Paulous , et al. August 15, 2	2000-08-15
In vitro diagnostic assay employing HIV-2 antigens for the detection of HIV-2 specific antibodies Grant 6,048,685 - Alizon , et al. April 11, 2	2000-04-11
DNA probes of human immunodeficiency virus type 2 (HIV-2), and methods employing these probes for dectecting the presence of HIV-2 Grant 5,310,651 - Alizon , et al. May 10, 1	1994-05-10
Methods and kits for diagnosing human immunodeficiency virus type 2(HIV-2) Grant 5,306,614 - Alizon , et al. * April 26, 1	1994-04-26
Immunological complex comprising an antigen of Simian Immunodeficiency Virus (SIV) and an antibody against human immunodeficiency virus type 2 (HIV 2), and method and kit for detecting antibodies to HIV-2 reactive with antigens of SIV Grant 5,268,265 - Montagnier , et al. * December 7, 1	1993-12-07
Method and kit or detecting antibodies to antigens of Human Immunodeficiency Virus type 2 (HIV-2) Grant 5,055,391 - Montagnier , et al. October 8, 1	1991-10-08
Peptides related to human immunodeficiency virus II (HIV-2) Grant 5,051,496 - Alizon , et al. September 24, 1	1991-09-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.